共 106 条
[1]
Tan Z(2021)Liver fibrosis: therapeutic targets and advances in drug therapy Front Cell Dev Biol 9 1-18
[2]
Sun H(2021)Liver transplantation in acute-on-chronic liver failure Transplantation 105 1471-1481
[3]
Xue T(2021)Molecular and cellular mechanisms of liver fibrosis and its regression Nat Rev Gastroenterol Hepatol 18 151-166
[4]
Karvellas CJ(2022)Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis Drug Discov Today 27 1044-1061
[5]
Francoz C(2013)Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology Nat Commun 4 1-11
[6]
Weiss E(2017)Hepatic stellate cells as key target in liver fibrosis Adv Drug Deliv Rev 121 27-42
[7]
Kisseleva T(2017)Hepatic stellate cell activation and pro-fibrogenic signals J Hepatol 67 1104-1105
[8]
Brenner D(2019)Fucoxanthin exerts anti-fibrogenic effects in hepatic stellate cellsBo Biochem Biophys Res Commun 513 657-662
[9]
Baghaei K(2021)Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells J Agric Food Res 6 100245-25
[10]
Mazhari S(2022)Fucoxanthin: a promising phytochemical on diverse pharmacological targets Front Pharmacol 13 1-310